Almagate
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | Al2Mg6(OH)14(CO3)2 · 4 H2O |
Molar mass | 314.99 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]
Adverse effects
Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]
References
- ↑ PMID 6548918 (PMID 6548918)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 6439224 (PMID 6439224)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ PMID 6548926 (PMID 6548926)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Categories:
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Antacids
- Aluminium compounds
- Magnesium compounds